Format
Sort by
Items per page

Send to

Choose Destination

Best matches for porphyria cutanea tarda treatment:

Sporadic porphyria cutanea tarda: treatment with chloroquine decreases hyperglycemia and reduces development of metabolic syndrome. González-Estrada A et al. Eur J Intern Med. (2014)

The porphyrias: advances in diagnosis and treatment. Balwani M et al. Hematology Am Soc Hematol Educ Program. (2012)

Hepatitis C, porphyria cutanea tarda and liver iron: an update. Ryan Caballes F et al. Liver Int. (2012)

Search results

Items: 1 to 20 of 889

1.

Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.

Takata K, Shakado S, Sakamoto K, Fukuda H, Yamauchi R, Fukuda S, Kunimoto H, Umeda K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Sakisaka S.

Clin J Gastroenterol. 2017 Sep 7. doi: 10.1007/s12328-017-0772-x. [Epub ahead of print]

PMID:
28884440
2.

Porphyria.

Bissell DM, Anderson KE, Bonkovsky HL.

N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634. Review. No abstract available.

PMID:
28854095
3.

Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L.

Clin Rev Allergy Immunol. 2017 Jul 16. doi: 10.1007/s12016-017-8625-4. [Epub ahead of print] Review.

PMID:
28712039
4.

Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda.

Singal AK, Venkata KVR, Jampana S, Islam FU, Anderson KE.

Am J Med Sci. 2017 Jun;353(6):523-528. doi: 10.1016/j.amjms.2017.03.007. Epub 2017 Mar 8.

PMID:
28641714
5.

The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.

Mahale P, Engels EA, Li R, Torres HA, Hwang LY, Brown EL, Kramer JR.

Gut. 2017 Jun 20. pii: gutjnl-2017-313983. doi: 10.1136/gutjnl-2017-313983. [Epub ahead of print]

PMID:
28634198
6.

Sporadic Porphyria in a patient with stage II melanoma treated with interferon α.

Reymann V, Girard C, Dereure O, Guillot B, Du Thanh A.

Curr Drug Saf. 2017 May 2. doi: 10.2174/1574886312666170502163628. [Epub ahead of print]

PMID:
28464763
7.

Performing therapeutic venesection in a doctor's surgery.

Hy L, Ho HW.

Aust Fam Physician. 2017 Mar;46(3):132-138. Review.

8.

Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.

Wiznia LE, Laird ME, Franks AG Jr.

J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1260-1270. doi: 10.1111/jdv.14186. Epub 2017 Mar 29. Review.

PMID:
28252812
9.

Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose.

Rodrigues N, Caeiro F, Santana A, Mendes T, Lopes L.

Case Rep Nephrol. 2017;2017:4591871. doi: 10.1155/2017/4591871. Epub 2017 Jan 22.

10.

Hepatoerythropoietic Porphyria.

Liu LU, Phillips J, Bonkovsky H; Porphyrias Consortium of the Rare Diseases Clinical Research Network.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2013 Oct 31 [updated 2016 Dec 22].

11.

Photodermatoses: Kids are not just little people.

Naka F, Shwayder TA, Santoro FA.

Clin Dermatol. 2016 Nov - Dec;34(6):724-735. doi: 10.1016/j.clindermatol.2016.07.007. Epub 2016 Jul 12.

PMID:
27968932
12.

Hepatic porphyria: A narrative review.

Arora S, Young S, Kodali S, Singal AK.

Indian J Gastroenterol. 2016 Nov;35(6):405-418. Epub 2016 Oct 31. Review.

PMID:
27796941
13.

Acute intermittent porphyria precipitated by atazanavir/ritonavir.

Bharti S, Malhotra P, Hirsch B.

Int J STD AIDS. 2016 Nov;27(13):1234-1235. Epub 2016 Feb 11.

PMID:
26872826
14.

Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.

Tong Y, Song YK, Tyring S.

JAMA Dermatol. 2016 Dec 1;152(12):1393-1395. doi: 10.1001/jamadermatol.2016.3036. No abstract available.

PMID:
27732687
15.

Familial Porphyria Cutanea Tarda.

Liu LU, Phillips J, Bonkovsky H; Porphyrias Consortium of the Rare Diseases Clinical Research Network.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2013 Jun 6 [updated 2016 Sep 8].

16.

Porphyria cutanea tarda in a HIV- positive patient.

Franzon VA, Mikilita ES, Camelo FH, Camargo R.

An Bras Dermatol. 2016 Jul-Aug;91(4):520-3. doi: 10.1590/abd1806-4841.20163808.

17.

Clinical applications of therapeutic phlebotomy.

Kim KH, Oh KY.

J Blood Med. 2016 Jul 18;7:139-44. doi: 10.2147/JBM.S108479. eCollection 2016.

18.

[Treatment by bloodletting in the past and present].

Colović N, Leković D, Gotić M.

Srp Arh Celok Lek. 2016 Mar-Apr;144(3-4):240-8. Serbian.

PMID:
27483574
19.

Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children.

Tu JH, Sheu SL, Teng JM.

JAMA Dermatol. 2016 Nov 1;152(11):1258-1261. doi: 10.1001/jamadermatol.2016.2303.

PMID:
27410690
20.

Cutaneous Porphyrias: Causes, Symptoms, Treatments and the Danish Incidence 1989-2013.

Christiansen AL, Aagaard L, Krag A, Rasmussen LM, Bygum A.

Acta Derm Venereol. 2016 Nov 2;96(7):868-872. doi: 10.2340/00015555-2444.

Supplemental Content

Loading ...
Support Center